Search Results - "Wittenborn JS"

Influence of Anti-VEGF Injections on Longitudinal Changes in Vascular Metrics Measured by OCTA in Age Related Macular Degeneration: A Retrospective Real-World Study.

Authors: Zhu, Ying Gumustop, Selin S Wang, Leiyu et al.

Source: Clinical Ophthalmology. May2026, Vol. 20, p1-8. 8p.

Current global estimates, risk factors, and knowledge gaps for Hepatitis E virus (HEV): A scoping review.

Authors: Ahmed, Md Koushik Maroofi, Hanna Blunt, Madeleine et al.

Source: PLoS Neglected Tropical Diseases. 3/11/2026, Vol. 20 Issue 3, p1-46. 46p.

Explainable AI for glaucoma detection and classification: a comprehensive review.

Authors: Abd El-Gawad, Ahmed M. Hassan, Sarah Elsharkawy, Mohamed et al.

Source: Artificial Intelligence Review; Jul2026, Vol. 59 Issue 7, p1-59, 59p

"You never know what's in front of you": A mixed methods study of barriers and facilitators to physical activity among blind and low-vision adults with type 2 diabetes.

Authors: Nicklett, Emily J. Stensland, Meredith L. Qin, Weidi et al.

Source: PLoS ONE. 6/17/2026, Vol. 21 Issue 6, p1-29. 29p.

Comparison of the Syringe Preparation Time for Ranibizumab Prefilled Syringe versus Bevacizumab, Ranibizumab, and Aflibercept Vials.

Authors: Somuncu, Ahmet Mehmet Uğurlu, Adem Taşlı, Nurdan Gamze et al.

Source: Archives of Basic & Clinical Research. 2026, Vol. 8 Issue 2, p189-193. 5p.

Efficacy of Netarsudil in Open and Closed Angle Glaucomas Within the Vietnamese Population: A Single-Center, Retrospective Study.

Authors: Truong, Dzuy Nguyen, Kelly C Chansangpetch, Sunee et al.

Source: Clinical Ophthalmology. May2026, Vol. 20, p1-9. 9p.

Assessment of newly designed fonts for visual accessibility.

Authors: Legge, Gordon E. Xiong, Yingzi Gao, Qingying et al.

Source: PLoS ONE. 3/24/2026, Vol. 21 Issue 3, p1-16. 16p.

The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature Review.

Authors: Rahhal, Firas Zhang, Jun Mukherjee, Munia

Source: Ophthalmology & Therapy. Mar2026, Vol. 15 Issue 3, p925-943. 19p.

Trends in First-Line Glaucoma Treatment from 2013 to 2024: A Multi-institutional and Multinational Cohort Study.

Authors: Chuang, Lan-Hsin Tsai, Daniel Hsiang-Te Chan, Yuan-Hsi et al.

Source: Ophthalmology & Therapy. Mar2026, Vol. 15 Issue 3, p1083-1094. 12p.

Mapping disparities in diabetic eye exam adherence using geographic information systems.

Authors: Dogra, Neil Sai Geiss, Michael Patrick Gearinger, Talia et al.

Source: PLoS ONE. 2/13/2026, Vol. 21 Issue 2, p1-12. 12p.

Disparities in Vision-Related Functional Impairments Among Adults in the United States.

Authors: Zajner, Chris Patil, Nikhil Xie, Jim S. et al.

Source: Ophthalmic Epidemiology. Feb2026, Vol. 33 Issue 1, p109-115. 7p.

Cross-Sectional Survey of Real-World Physician Prescribing Practices for Anti-VEGF Agents in the Treatment of Neovascular Age-Related Macular Degeneration and Associated Patient Burden in the United States.

Authors: Gulati, Shilpa Coak, Emily Mascia, Daniel et al.

Source: Clinical Ophthalmology. Feb2026, Vol. 20, p1-16. 16p.

A Systematic Review and Meta-Analysis Assessing Diversity and Representation in Diabetic Retinopathy Clinical Trials in the U.S.

Authors: Elghzali, Ahmed Swami, Vinay Hossain, M. D. et al.

Source: Ophthalmic Epidemiology. Oct2025, Vol. 32 Issue 5, p465-475. 11p.

Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.

Authors: Baljoon, Ahmead Diaby, Vakaramoko Suther, Sandra et al.

Source: PharmacoEconomics - Open. May2026, Vol. 10 Issue 3, p457-469. 13p.

Economic Burden of Age-Related Macular Degeneration and Diabetic Macular Edema in Slovakia: a Cost-of-illness Analysis.

Authors: Ladislav, Janco Jana, Stefanickova Beata, Busanyova et al.

Source: Bratislava Medical Journal / Bratislavské Lekárske Listy. Apr2025, Vol. 126 Issue 4, p544-551. 8p.

Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials.

Authors: Friedman, Scott M. Xu, Yingxin Sherman, Steven et al.

Source: Ophthalmology & Therapy. Nov2025, Vol. 14 Issue 11, p2919-2936. 18p.

Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.

Authors: Kuznik, Andreas Coughlan, Anna Pinsent, Amy et al.

Source: Ophthalmology & Therapy. Nov2025, Vol. 14 Issue 11, p2863-2875. 13p.

A Scoping Review of Methods for Extrapolating Costs and Effects in Economic Evaluations of Remote Monitoring.

Authors: Raunbak SM Christensen JJ Weinreich UM et al.

Source: PharmacoEconomics - open [Pharmacoecon Open] 2026 Jul 10. Date of Electronic Publication: 2026 Jul 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101700780 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-4254 (Electronic) Linking ISSN: 25094262 NLM ISO Abbreviation: Pharmacoecon Open

Hepatitis E virus in the Kathmandu Valley: Insights from a representative longitudinal serosurvey.

Authors: Katuwal, Nishan Thapa, Melina Shrestha, Sony et al.

Source: PLoS Neglected Tropical Diseases. 8/5/2024, Vol. 18 Issue 8, p1-14. 14p.

Rapid Macular Thinning as a Biomarker for Geographical Atrophy.

Authors: Cukurova, Feyza Ramsey, David J

Source: Clinical Ophthalmology. May2026, Vol. 20, p1-11. 11p.